Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes

OBJECTIVE: To assess the long-term cost-effectiveness of aspirin use among adults aged ≥40 years with newly diagnosed type 2 diabetes. RESEARCH DESIGN AND METHODS: We used a validated cost-effectiveness model of type 2 diabetes to assess the lifetime health and cost consequences of use or nonuse of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Zhang, Ping, Barker, Lawrence E., Hoerger, Thomas J.
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875422/
https://www.ncbi.nlm.nih.gov/pubmed/20332350
http://dx.doi.org/10.2337/dc09-1888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875422/
https://www.ncbi.nlm.nih.gov/pubmed/20332350
http://dx.doi.org/10.2337/dc09-1888

Ejemplares similares